PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1290847
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1290847
Biologics Outsourcing Market with COVID-19 Impact Analysis, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
The Biologics Outsourcing Market size was valued at USD 80,410.3 million in 2022, expanding at a CAGR of 18.7% from 2023 to 2030.
Biologics are a more complex class of medicines to manufacture, package, store, and distribute than their chemical counterparts. Outsourcing of any aspect of the supply chain means pharmaceutical companies and their chosen vendors need to work in true partnership, navigating the complex process together to ensure speed to market. Developing and manufacturing biologic drugs in-house can be costly due to the need for specialized facilities, equipment, and personnel. Outsourcing allows companies to avoid or reduce these capital investments and instead pay for specific services or processes as needed, potentially resulting in cost savings.
Biologics Outsourcing Market- Market Dynamics
Increasing trend of outsourcing among biopharma companies to gain economical access to advanced biologics development and manufacturing capacities is expected to propel market growth
The increasing trend of outsourcing in the biopharmaceutical industry enables companies to gain access to advanced biologics development and manufacturing capacities in a cost-effective manner. Outsourcing allows companies to access advanced facilities, equipment, and expertise without the need for substantial capital investments. contract research organizations (CROs)and contract manufacturing organizations (CMOs) are equipped with experienced scientists and technicians who possess the necessary skills to handle complex biologics processes. There are 2,823 Contract Research Organizations businesses in the US as of 2023, an increase of 0.9% from 2022. The highest costs for business in The Contract Research Organizations industry in the US as a percentage of revenue are Wages (29.1%), Purchases (6.8%), and Rent & Utilities (3.4%, according to industry statistics of U.S. By leveraging the expertise and infrastructure of outsourcing partners, companies can optimize their operations, reduce financial risks, and accelerate the commercialization of their biologic products.
Biologics Outsourcing Market- Key Insights
- As per the analysis shared by our research analyst, the global Biologics outsourcing market is estimated to grow annually at a CAGR of around XX% over the forecast period (2023-2030)
- The Biologics outsourcing industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
- Based on product type segmentation, Antibody was the leading type in 2022
- Based on Application segmentation, Therapeutics was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Biologics Outsourcing Market- Segmentation Analysis:
The Global Biologics Outsourcing Market is segmented on the basis of specificity, Type, Application, and Region.
The market is divided into five categories based on Product Type: Antibody, Recombinant, Protein, Vaccines, and Others. Antibody dominates the market. These are commonly outsourced types of biological products. Antibodies are proteins produced by the immune system in response to the presence of foreign substances, such as pathogens or abnormal cells. Outsourcing the development and manufacturing of antibodies can offer several advantages to biopharmaceutical companies.
The market is divided into three categories based on Application: Therapeutics, Diagnostics, and Research. Therapeutics dominate the market and are likely to maintain their dominance during the forecast period. Biologics Outsources are used for therapeutic purposes, often to treat complex diseases like cancer, autoimmune disorders, or genetic diseases. The biologics outsourcing market refers to the outsourcing of various processes related to the development, manufacturing, and commercialization of biologic drugs or therapeutics.
Biologics Outsourcing Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate Biologics Outsourcing Market, due to increasing R&D spend of biopharma companies and escalating approvals and uptake of biosimilar. Biopharmaceutical companies in North America have been allocating significant resources to research and development activities. This focus on R&D allows them to develop innovative biologic drugs and therapies. Pharmaceutical Research and Manufacturers of America predicted that the U.S. biopharmaceutical industry has been the world leader in the development of new medicines, and PhRMA member companies continue to be at the forefront. The entire U.S. biopharmaceutical invested an estimated USD122 billion in R&D in 2020. Europe and Asia Pacific are expected to propel significant growth in Biologics Outsourcing Market, due to the Technological advancements in cell line engineering (gene editing tools) & cell line development technologies.
Biologics Outsourcing Market- Competitive Landscape:
Companies invest heavily in research and development to enhance their cell line development technologies, develop new products, and explore novel therapeutic applications. These players offer a wide range of services, including contract research, contract manufacturing, clinical trial services, and other support services for biopharmaceutical companies The Biologics outsourcing market is highly competitive, with several companies vying for market share. For instance, in 2023, Boehringer Ingelheim opens a USD386m German R&D plant. The Biologics Development Center (BDC) will develop antibodies and therapeutic proteins and manufacture substances for clinical trials, says Boehringer Ingelheim. The growth of biosimilar and the need for their development and manufacturing are also contributing to the demand for biologics outsourcing. Biosimilar developers often rely on outsourcing partners to leverage their expertise and infrastructure.
Recent Developments:
In April 2022, Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize the development, launch, and supply of better patient treatments across multiple modalities, nowadays announced the acquisition from Vaccine Manufacturing and Innovation Centre UK Limited (VMIC Ltd.) of a biologics development and manufacturing facility currently under construction near Oxford, U.K.
Key features of the study:
- This proposed research study on Biologics outsourcing market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the Biologics outsourcing market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Biologics outsourcing market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Biologics outsourcing market
- Impact of COVID-19 on Biologics outsourcing market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Biologics outsourcing market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Biologics outsourcing market, we have also included competitive landscape and key innovator analysis for the Biologics outsourcing market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Biologics outsourcing market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Biologics outsourcing market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOLOGICS OUTSOURCING MARKET KEY PLAYERS
- Boehringer Ingelheim
- Catalent
- GenScript
- Innovent Biologics
- Syngene
- Shanghai Medicilon
- GL Biochem Corporation
- GVK Biosciences Private
- Horizon Discovery Group
- Selexis
- Lonza
- Abzena
- Adimab
GLOBAL BIOLOGICS OUTSOURCING MARKET, BY PRODUCT TYPE
- Antibody
- Recombinant
- Protein
- Vaccines
- Others
GLOBAL BIOLOGICS OUTSOURCING MARKET, BY APPLICATION
- Therapeutics
- Diagnostics
- Research
GLOBAL BIOLOGICS OUTSOURCING MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Biologics Outsourcing Market Overview
- 1.1. Study Scope
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Biologics Outsourcing Market Snippet by Product Type
- 2.1.2. Biologics Outsourcing Market Snippet by Application
- 2.1.3. Biologics Outsourcing Market Snippet by Country
- 2.1.4. Biologics Outsourcing Market Snippet by Region
- 2.2. Competitive Insights
3. Biologics Outsourcing Key Market Trends
- 3.1. Biologics Outsourcing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Biologics Outsourcing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Biologics Outsourcing Market Opportunities
- 3.4. Biologics Outsourcing Market Future Trends
4. Biologics Outsourcing Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Biologics Outsourcing Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Biologics Outsourcing Market Landscape
- 6.1. Biologics Outsourcing Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Biologics Outsourcing Market - By Product Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
- 7.1.2. Antibody
- 7.1.3. Recombinant
- 7.1.4. Protein
- 7.1.5. Vaccines
- 7.1.6. Others
8. Biologics Outsourcing Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 8.1.2. Therapeutics
- 8.1.3. Diagnostics
- 8.1.4. Research
9. Biologics Outsourcing Market- By Geography
- 9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 9.2. North America
- 9.2.1. Overview
- 9.2.2. Biologics Outsourcing Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.2.6. U.S.
- 9.2.6.1. Overview
- 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.2.7. Canada
- 9.2.7.1. Overview
- 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3. Europe
- 9.3.1. Overview
- 9.3.2. Biologics Outsourcing Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.6. Germany
- 9.3.6.1. Overview
- 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.7. Italy
- 9.3.7.1. Overview
- 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.8. United Kingdom
- 9.3.8.1. Overview
- 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.9. France
- 9.3.9.1. Overview
- 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.10. Russia
- 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.11. Netherlands
- 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.12. Sweden
- 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.13. Poland
- 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.14. Rest of Europe
- 9.3.14.1. Overview
- 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Biologics Outsourcing Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.6. India
- 9.4.6.1. Overview
- 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.7. China
- 9.4.7.1. Overview
- 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.8. Japan
- 9.4.8.1. Overview
- 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.9. South Korea
- 9.4.9.1. Overview
- 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.10. Australia
- 9.4.10.1. Overview
- 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.11. Thailand
- 9.4.11.1. Overview
- 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.12. Indonesia
- 9.4.12.1. Overview
- 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.13. Philippines
- 9.4.13.1. Overview
- 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.14. Rest of APAC
- 9.4.14.1. Overview
- 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Biologics Outsourcing Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.6. Brazil
- 9.5.6.1. Overview
- 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.7. Mexico
- 9.5.7.1. Overview
- 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.8. Argentina
- 9.5.8.1. Overview
- 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.9. Colombia
- 9.5.9.1. Overview
- 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.10. Rest of LATAM
- 9.5.10.1. Overview
- 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Biologics Outsourcing Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.6. Saudi Arabia
- 9.6.6.1. Overview
- 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.7. United Arab Emirates
- 9.6.7.1. Overview
- 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.8. Israel
- 9.6.8.1. Overview
- 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.9. Turkey
- 9.6.9.1. Overview
- 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.10. Algeria
- 9.6.10.1. Overview
- 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.11. Egypt
- 9.6.11.1. Overview
- 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.12. Rest of MEA
- 9.6.12.1. Overview
- 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Biologics Outsourcing Industry
- 10.1. Competitive Dashboard
- 10.2. Company Profiles
- 10.2.1. Boehringer Ingelheim
- 10.2.2. Catalent
- 10.2.3. GenScript
- 10.2.4. Innovent Biologics
- 10.2.5. Syngene
- 10.2.6. Shanghai Medicilon
- 10.2.7. GL Biochem Corporation
- 10.2.8. GVK Biosciences Private
- 10.2.9. Horizon Discovery Group
- 10.2.10. Selexis
- 10.2.11. Lonza
- 10.2.12. Abzena
- 10.2.13. Adimab
11. 360 Degree Analyst View
12. Appendix
- 12.1. Research Methodology
- 12.2. References
- 12.3. Abbreviations
- 12.4. Disclaimer
- 12.5. Contact Us
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Biologics Outsourcing Market: Product Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Product Type
- TABLE Global Biologics Outsourcing Market, by Product Type 2018-2030 (USD Million)
- TABLE Biologics Outsourcing Market: Application Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global Biologics Outsourcing Market, by Application 2018-2030 (USD Million)
- TABLE Biologics Outsourcing Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Biologics Outsourcing Market, by Region 2018-2030 (USD Million)
- TABLE North America Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
- TABLE North America Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
- TABLE North America Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
- TABLE Europe Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
- TABLE Europe Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
- TABLE Asia Pacific Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
- TABLE Latin America Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
- TABLE Latin America Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
- TABLE Middle East and Africa Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
